Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program.

Soler J, Elices M, Dominguez-Clavé E, Pascual JC, Feilding A, Navarro-Gil M, García-Campayo J, Riba J.

Front Pharmacol. 2018 Mar 20;9:224. doi: 10.3389/fphar.2018.00224. eCollection 2018.

2.

Correction to: The hidden therapist: evidence for a central role of music in psychedelic therapy.

Kaelen M, Giribaldi B, Raine J, Evans L, Timmermann C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R.

Psychopharmacology (Berl). 2018 May;235(5):1623. doi: 10.1007/s00213-018-4886-8.

3.

The hidden therapist: evidence for a central role of music in psychedelic therapy.

Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R.

Psychopharmacology (Berl). 2018 Feb;235(2):505-519. doi: 10.1007/s00213-017-4820-5. Epub 2018 Feb 2. Erratum in: Psychopharmacology (Berl). 2018 Mar 26;:.

4.

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ.

Psychopharmacology (Berl). 2018 Feb;235(2):399-408. doi: 10.1007/s00213-017-4771-x. Epub 2017 Nov 8.

5.

The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.

Morales-García JA, de la Fuente Revenga M, Alonso-Gil S, Rodríguez-Franco MI, Feilding A, Perez-Castillo A, Riba J.

Sci Rep. 2017 Jul 13;7(1):5309. doi: 10.1038/s41598-017-05407-9.

6.

Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.

Sampedro F, de la Fuente Revenga M, Valle M, Roberto N, Domínguez-Clavé E, Elices M, Luna LE, Crippa JAS, Hallak JEC, de Araujo DB, Friedlander P, Barker SA, Álvarez E, Soler J, Pascual JC, Feilding A, Riba J.

Int J Neuropsychopharmacol. 2017 Sep 1;20(9):698-711. doi: 10.1093/ijnp/pyx036.

7.

Altered Insula Connectivity under MDMA.

Walpola IC, Nest T, Roseman L, Erritzoe D, Feilding A, Nutt DJ, Carhart-Harris RL.

Neuropsychopharmacology. 2017 Oct;42(11):2152-2162. doi: 10.1038/npp.2017.35. Epub 2017 Feb 14.

8.

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.

Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ.

Lancet Psychiatry. 2016 Jul;3(7):619-27. doi: 10.1016/S2215-0366(16)30065-7. Epub 2016 May 17.

9.

LSD-induced entropic brain activity predicts subsequent personality change.

Lebedev AV, Kaelen M, Lövdén M, Nilsson J, Feilding A, Nutt DJ, Carhart-Harris RL.

Hum Brain Mapp. 2016 Sep;37(9):3203-13. doi: 10.1002/hbm.23234. Epub 2016 May 6.

10.

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.

Roseman L, Sereno MI, Leech R, Kaelen M, Orban C, McGonigle J, Feilding A, Nutt DJ, Carhart-Harris RL.

Hum Brain Mapp. 2016 Aug;37(8):3031-40. doi: 10.1002/hbm.23224. Epub 2016 Apr 29.

11.

Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.

Tagliazucchi E, Roseman L, Kaelen M, Orban C, Muthukumaraswamy SD, Murphy K, Laufs H, Leech R, McGonigle J, Crossley N, Bullmore E, Williams T, Bolstridge M, Feilding A, Nutt DJ, Carhart-Harris R.

Curr Biol. 2016 Apr 25;26(8):1043-50. doi: 10.1016/j.cub.2016.02.010. Epub 2016 Apr 13.

12.

LSD modulates music-induced imagery via changes in parahippocampal connectivity.

Kaelen M, Roseman L, Kahan J, Santos-Ribeiro A, Orban C, Lorenz R, Barrett FS, Bolstridge M, Williams T, Williams L, Wall MB, Feilding A, Muthukumaraswamy S, Nutt DJ, Carhart-Harris R.

Eur Neuropsychopharmacol. 2016 Jul;26(7):1099-109. doi: 10.1016/j.euroneuro.2016.03.018. Epub 2016 Apr 12.

PMID:
27084302
13.

Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, Tagliazucchi E, Schenberg EE, Nest T, Orban C, Leech R, Williams LT, Williams TM, Bolstridge M, Sessa B, McGonigle J, Sereno MI, Nichols D, Hellyer PJ, Hobden P, Evans J, Singh KD, Wise RG, Curran HV, Feilding A, Nutt DJ.

Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4853-8. doi: 10.1073/pnas.1518377113. Epub 2016 Apr 11.

14.

A placebo-controlled investigation of synaesthesia-like experiences under LSD.

Terhune DB, Luke DP, Kaelen M, Bolstridge M, Feilding A, Nutt D, Carhart-Harris R, Ward J.

Neuropsychologia. 2016 Jul 29;88:28-34. doi: 10.1016/j.neuropsychologia.2016.04.005. Epub 2016 Apr 5.

15.

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.

Valle M, Maqueda AE, Rabella M, Rodríguez-Pujadas A, Antonijoan RM, Romero S, Alonso JF, Mañanas MÀ, Barker S, Friedlander P, Feilding A, Riba J.

Eur Neuropsychopharmacol. 2016 Jul;26(7):1161-75. doi: 10.1016/j.euroneuro.2016.03.012. Epub 2016 Mar 25.

PMID:
27039035
16.

Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide.

Speth J, Speth C, Kaelen M, Schloerscheidt AM, Feilding A, Nutt DJ, Carhart-Harris RL.

J Psychopharmacol. 2016 Apr;30(4):344-53. doi: 10.1177/0269881116628430.

17.

Ayahuasca: Pharmacology, neuroscience and therapeutic potential.

Domínguez-Clavé E, Soler J, Elices M, Pascual JC, Álvarez E, de la Fuente Revenga M, Friedlander P, Feilding A, Riba J.

Brain Res Bull. 2016 Sep;126(Pt 1):89-101. doi: 10.1016/j.brainresbull.2016.03.002. Epub 2016 Mar 11. Review.

PMID:
26976063
18.

The paradoxical psychological effects of lysergic acid diethylamide (LSD).

Carhart-Harris RL, Kaelen M, Bolstridge M, Williams TM, Williams LT, Underwood R, Feilding A, Nutt DJ.

Psychol Med. 2016 May;46(7):1379-90. doi: 10.1017/S0033291715002901. Epub 2016 Feb 5.

19.

Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.

Soler J, Elices M, Franquesa A, Barker S, Friedlander P, Feilding A, Pascual JC, Riba J.

Psychopharmacology (Berl). 2016 Mar;233(5):823-9. doi: 10.1007/s00213-015-4162-0. Epub 2015 Nov 27.

PMID:
26612618
20.

LSD enhances the emotional response to music.

Kaelen M, Barrett FS, Roseman L, Lorenz R, Family N, Bolstridge M, Curran HV, Feilding A, Nutt DJ, Carhart-Harris RL.

Psychopharmacology (Berl). 2015 Oct;232(19):3607-14. doi: 10.1007/s00213-015-4014-y. Epub 2015 Aug 11.

21.

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.

Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL.

Hum Brain Mapp. 2015 Aug;36(8):3137-53. doi: 10.1002/hbm.22833. Epub 2015 May 22.

PMID:
26010878
22.

LSD enhances suggestibility in healthy volunteers.

Carhart-Harris RL, Kaelen M, Whalley MG, Bolstridge M, Feilding A, Nutt DJ.

Psychopharmacology (Berl). 2015 Feb;232(4):785-94. doi: 10.1007/s00213-014-3714-z. Epub 2014 Sep 23.

PMID:
25242255
23.

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.

Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL.

Front Hum Neurosci. 2014 May 27;8:204. doi: 10.3389/fnhum.2014.00204. eCollection 2014.

24.

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.

Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D.

Front Hum Neurosci. 2014 Feb 3;8:20. doi: 10.3389/fnhum.2014.00020. eCollection 2014.

25.

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.

Carhart-Harris RL, Murphy K, Leech R, Erritzoe D, Wall MB, Ferguson B, Williams LT, Roseman L, Brugger S, De Meer I, Tanner M, Tyacke R, Wolff K, Sethi A, Bloomfield MA, Williams TM, Bolstridge M, Stewart L, Morgan C, Newbould RD, Feilding A, Curran HV, Nutt DJ.

Biol Psychiatry. 2015 Oct 15;78(8):554-62. doi: 10.1016/j.biopsych.2013.12.015. Epub 2014 Jan 10.

26.

The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.

Carhart-Harris RL, Wall MB, Erritzoe D, Kaelen M, Ferguson B, De Meer I, Tanner M, Bloomfield M, Williams TM, Bolstridge M, Stewart L, Morgan CJ, Newbould RD, Feilding A, Curran HV, Nutt DJ.

Int J Neuropsychopharmacol. 2014 Apr;17(4):527-40. doi: 10.1017/S1461145713001405. Epub 2013 Dec 17.

PMID:
24345398
27.

Broadband cortical desynchronization underlies the human psychedelic state.

Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ.

J Neurosci. 2013 Sep 18;33(38):15171-83. doi: 10.1523/JNEUROSCI.2063-13.2013.

28.

Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users.

Morgan CJ, Noronha LA, Muetzelfeldt M, Feilding A, Curran HV.

J Psychopharmacol. 2013 Jun;27(6):497-506. doi: 10.1177/0269881113477744. Epub 2013 Feb 25. Erratum in: J Psychopharmacol. 2015 Sep;29(9):NP1. Fielding, Amanda [corrected to Feilding, Amanda].

29.

Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.

Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ.

Schizophr Bull. 2013 Nov;39(6):1343-51. doi: 10.1093/schbul/sbs117. Epub 2012 Oct 8.

30.

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.

Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, Stone JM, Reichenberg A, Brenneisen R, Holt D, Feilding A, Walker L, Murray RM, Kapur S.

J Psychopharmacol. 2013 Jan;27(1):19-27. doi: 10.1177/0269881112460109. Epub 2012 Oct 5.

PMID:
23042808
31.

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ.

Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2138-43. doi: 10.1073/pnas.1119598109. Epub 2012 Jan 23.

32.

Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.

Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ.

Br J Psychiatry. 2012 Mar;200(3):238-44. doi: 10.1192/bjp.bp.111.103309. Epub 2012 Jan 26.

PMID:
22282432
33.

Investigating the interaction between schizotypy, divergent thinking and cannabis use.

Schafer G, Feilding A, Morgan CJ, Agathangelou M, Freeman TP, Valerie Curran H.

Conscious Cogn. 2012 Mar;21(1):292-8. doi: 10.1016/j.concog.2011.11.009. Epub 2012 Jan 9.

34.

Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherence.

Stone JM, Morrison PD, Brugger S, Nottage J, Bhattacharyya S, Sumich A, Wilson D, Tunstall N, Feilding A, Brenneisen R, McGuire P, Murray RM, Ffytche DH.

Mol Psychiatry. 2012 Jun;17(6):568-9. doi: 10.1038/mp.2011.141. Epub 2011 Nov 1. No abstract available.

PMID:
22042229
35.

Delta-9-tetrahydrocannabinol disruption of time perception and of self-timed actions.

Stone JM, Morrison PD, Nottage J, Bhattacharyya S, Feilding A, McGuire PK.

Pharmacopsychiatry. 2010 Aug;43(6):236-7. doi: 10.1055/s-0030-1255030. Epub 2010 Jul 22. No abstract available.

PMID:
20652859
36.

The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.

Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, Nutt DJ.

J Psychopharmacol. 2011 Nov;25(11):1562-7. doi: 10.1177/0269881110367445. Epub 2010 Apr 15.

PMID:
20395317
37.

Slow-wave oscillations in the craniosacral space: a hemoliquorodynamic concept of origination.

Moskalenko YE, Kravchenko TI, Vainshtein GB, Halvorson P, Feilding A, Mandara A, Panov AA, Semernya VN.

Neurosci Behav Physiol. 2009 May;39(4):377-81. doi: 10.1007/s11055-009-9140-8. Epub 2009 Apr 2.

PMID:
19340579
38.

[Biomechanical properties of the human cranium: aging aspects].

Moskalenko IuE, Vaĭnshteĭn GB, Hal'vorson P, Kravchenko TI, Feĭlding A, Riabchikova NA, Semernia VN, Panov AA.

Zh Evol Biokhim Fiziol. 2008 Sep-Oct;44(5):513-20. Russian.

PMID:
18959215
39.

[The effect of craniotomy on the intracranial hemodynamics and cerebrospinal fluid dynamics in humans].

Moskalenko IuE, Vaĭnshteĭn GB, Kravchenko TI, Mozhaev SV, Semernia VN, Feilding A, Halvorson P, Medvedev SV.

Fiziol Cheloveka. 2008 May-Jun;34(3):41-8. Russian. No abstract available.

PMID:
18677946
40.

[Slow-wave fluctuations in craniosacral space: hemo-liquorodynamic conception of origin].

Moskalenko IuE, Kravchenko TI, Baĭnshteĭn GB, Khal'vorson P, Feĭlding A, Mandara A, Panov AA, Semernia VN.

Ross Fiziol Zh Im I M Sechenova. 2008 Apr;94(4):441-7. Russian.

PMID:
18666638

Supplemental Content

Loading ...
Support Center